These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27732084)

  • 1. RABL2 Is Required for Hepatic Fatty Acid Homeostasis and Its Dysfunction Leads to Steatosis and a Diabetes-Like State.
    Yi Lo JC; O'Connor AE; Andrews ZB; Lo C; Tiganis T; Watt MJ; O'Bryan MK
    Endocrinology; 2016 Dec; 157(12):4732-4743. PubMed ID: 27732084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.
    Andrés-Blasco I; Herrero-Cervera A; Vinué Á; Martínez-Hervás S; Piqueras L; Sanz MJ; Burks DJ; González-Navarro H
    J Endocrinol; 2015 Dec; 227(3):179-91. PubMed ID: 26423094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
    Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
    Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
    Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function.
    Item F; Wueest S; Lemos V; Stein S; Lucchini FC; Denzler R; Fisser MC; Challa TD; Pirinen E; Kim Y; Hemmi S; Gulbins E; Gross A; O'Reilly LA; Stoffel M; Auwerx J; Konrad D
    Nat Commun; 2017 Sep; 8(1):480. PubMed ID: 28883393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
    Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis.
    Beaulant A; Dia M; Pillot B; Chauvin MA; Ji-Cao J; Durand C; Bendridi N; Chanon S; Vieille-Marchiset A; Da Silva CC; Patouraux S; Anty R; Iannelli A; Tran A; Gual P; Vidal H; Gomez L; Paillard M; Rieusset J
    J Hepatol; 2022 Sep; 77(3):710-722. PubMed ID: 35358616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.
    Newberry EP; Xie Y; Kennedy SM; Luo J; Davidson NO
    Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
    Sachithanandan N; Fam BC; Fynch S; Dzamko N; Watt MJ; Wormald S; Honeyman J; Galic S; Proietto J; Andrikopoulos S; Hevener AL; Kay TW; Steinberg GR
    Hepatology; 2010 Nov; 52(5):1632-42. PubMed ID: 20799351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.
    Liu W; Cao H; Ye C; Chang C; Lu M; Jing Y; Zhang D; Yao X; Duan Z; Xia H; Wang YC; Jiang J; Liu MF; Yan J; Ying H
    Nat Commun; 2014 Dec; 5():5684. PubMed ID: 25471065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.
    Thomas A; Belaidi E; Aron-Wisnewsky J; van der Zon GC; Levy P; Clement K; Pepin JL; Godin-Ribuot D; Guigas B
    Sci Rep; 2016 Apr; 6():24618. PubMed ID: 27094951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch1 deficiency decreases hepatic lipid accumulation by induction of fatty acid oxidation.
    Song NJ; Yun UJ; Yang S; Wu C; Seo CR; Gwon AR; Baik SH; Choi Y; Choi BY; Bahn G; Kim S; Kwon SM; Park JS; Baek SH; Park TJ; Yoon K; Kim BJ; Mattson MP; Lee SJ; Jo DG; Park KW
    Sci Rep; 2016 Jan; 6():19377. PubMed ID: 26786165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network.
    Kim K; Boo K; Yu YS; Oh SK; Kim H; Jeon Y; Bhin J; Hwang D; Kim KI; Lee JS; Im SS; Yoon SG; Kim IY; Seong JK; Lee H; Fang S; Baek SH
    Nat Commun; 2017 Jul; 8(1):162. PubMed ID: 28757615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice.
    Sheng L; Liu Y; Jiang L; Chen Z; Zhou Y; Cho KW; Rui L
    PLoS One; 2013; 8(12):e83269. PubMed ID: 24358267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.